Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Medical Practitioner Delves into the Single Payer System: The Canadian’s Healthcare Delivery System
- 10/19/2018 2:05:50 PM
- How great could it be for a society to exist with such an efficient yet available to all healthcare services? Dr. Henry Krahn, a long practicing urologist, talks on his book “The Single Payer Healthcare System - Faults and Fixes” how the Canadian healthcare system can be improved so as to uphold its pride in the healthcare realm.
- Mission Bio Joins NIST to Offer the Only Single-Cell DNA Analysis Platform Providing Quality Control for CRISPR Gene Editing
- 10/18/2018 1:16:01 PM
- Today, Mission Bio, Inc., a pioneer in single-cell DNA analysis and precision genomics, announced its participation in the National Institute of Standards and Technology (NIST) Genome Editing Consortium, a first-of-its-kind organization established to address the need for increased confidence in genome editing technologies.
- Future Family Raises $10MM Series A to Bring a Netflix-Like Subscription Model to Fertility, Turning $25k Costs Into Plans Starting at $250/Month
- 10/18/2018 12:35:38 PM
- Future Family, the female-founded company making world-class fertility care accessible to women and couples nationwide, today announced it has raised $10 million in Series A funding led by Aspect Ventures, with participation from iNovia, BBG Ventures, LaunchCapital, RiverPark Ventures, Ulu Ventures, Day One Ventures, and Portfolia.
- United Nations agencies call for ban on virginity testing
- 10/18/2018 5:59:43 AM
- Virginity testing — a gynecological examination conducted under the belief that it determines whether a woman or girl has had vaginal intercourse — must end, says UN Human Rights, UN Women and the World Health Organization (WHO).
- Allergy Advocacy Association Launches New Program, Epi near You New York at St. John Fisher College
- 10/16/2018 10:32:16 PM
- Dr. Shahzad Mustafa and Jon Terry will present a free informational training program, Epi Near You New York, created by the Allergy Advocacy Association.
- Automated Packaging Systems Introduces 24-Inch Wide, High Loft AirPouch® FastWrap™ Protective Packaging Material
- 10/13/2018 11:51:11 PM
- Automated Packaging Systems, the world leader in high-reliability bagging systems, has introduced a new AirPouch® FastWrap™ cushioning wrap that is high loft and 24 inches wide.
- 2018 Nobel Prizes in Physics: An Insight Into the Winners and Their Accomplishments
- 10/11/2018 4:18:54 AM
- A special lecture on the story behind the 2018 Nobel Prize winners in Physics is scheduled to be held at UNIST on October 11, 2018. Jointly organized by the Department of Physics and the IBS Center for Soft and Living Matters at UNIST, the event invites Professor Hyuk Kyu Pak and Distinguished Professor François Amblard to share their insights on the recent announcement of …
- NERC pledges £100 million for postgraduate training
- 10/11/2018 4:12:06 AM
- The PhD training centres, known as DTPs, underpin the UK’s world-leading profile within the environmental science community and bring together universities, research organisations and partners from a wide range of backgrounds, including charities, non-governmental organisations, government bodies and industry leaders.
- AstraZeneca presents advances in improving treatment options for ovarian and lung cancer patients at ESMO 2018
- 10/9/2018 4:17:13 PM
- AstraZeneca and MedImmune, its global biologics research and development arm, will present 54 abstracts, including eight oral presentations and three late breakers, to the European Society of Medical Oncology (ESMO 2018) Congress in Munich, Germany, 19-23 October.
- Roche to present new positive data from its broad cancer immunotherapy programme and across a wide range of cancers at the European Society for Medical Oncology (ESMO) 2018 Congress
- 10/9/2018 2:59:39 PM
- • First positive Phase III study results for a cancer immunotherapy combination in breast cancer, with Tecentriq plus nab-paclitaxel • Positive data for both Alecensa in lung cancer and Tecentriq in lung and liver cancers • New pivotal results from the tumour-agnostic entrectinib study across a broad range of cancer types for people whose tumours have been …
- Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients
- 10/9/2018 2:42:06 PM
- • There is a critical need for safe and effective treatments for secondary progressive multiple sclerosis (SPMS) - a highly debilitating form of MS characterized by gradual, irreversible worsening of disability, largely independent of relapses • If approved, siponimod (BAF312) would be the first oral disease-modifying therapy with the potential to delay progression …
- Pfizer Announces Executive Leadership Team
- 10/9/2018 2:17:35 PM
- Pfizer Inc. (NYSE:PFE) today announced its executive team that will report to Albert Bourla, incoming Chief Executive Officer, coincident with the commencement of his new role effective January 1, 2019.
- Inventor of ENT surgical microscopes heralds digital age in visualization
- 10/8/2018 3:50:31 AM
- At this year’s AAO-HNSF Annual Meeting in Atlanta, USA, the ZEISS Medical Technology business segment presents its revolutionizing solutions for ENT (ear, nose and throat) surgery, TIVATO® 700 and EXTARO® 300.
- The Secret is Out: Laser Treatment Can Save Your Teeth
- 10/6/2018 1:19:17 AM
- There are a variety of treatment options for gum disease, all with a common goal -- killing the germs, remove the infection and close up the gum pockets.
- Janssen Announces Exclusive, Worldwide License Agreement with Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection
- 10/4/2018 11:42:23 AM
- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Janssen Pharmaceuticals, Inc., (Janssen) has entered into an agreement with Arrowhead Pharmaceuticals, Inc., (Arrowhead) for an exclusive, worldwide license to develop and commercialize ARO-HBV, a Phase 1/2 subcutaneous, ribonucleic acid interference (RNAi) therapy candidate being investigated for …
- Sanofi completes divestiture of Zentiva to Advent
- 10/4/2018 11:38:04 AM
- Sanofi has completed the previously announced divestment of its European generics business Zentiva to Advent International (Advent) effective September 30.
- Novartis licenses three novel anti-infective programs to Boston Pharmaceuticals
- 10/4/2018 11:24:13 AM
- Novartis announced today that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates that are part of the Novartis Infectious Diseases portfolio, which have the potential to address the need for new agents to treat antibiotic resistant Gram-negative infections.
- Pfizer Announces CEO Succession
- 10/4/2018 11:02:30 AM
- Pfizer Inc. (NYSE:PFE) today announced its Board of Directors has unanimously elected Dr. Albert Bourla, 56, Pfizer Chief Operating Officer (COO), to succeed Ian Read as CEO effective January 1, 2019.
- Fujifilm Presents Comprehensive Product Portfolio at CHEST 2018
- 10/4/2018 10:00:00 AM
- (Booth #837) – FUJIFILM Medical Systems U.S.A., Inc. —Endoscopy, will showcase its innovative portfolio of high-resolution, high-quality medical imaging devices at the American College of Chest Physicians Annual Meeting (CHEST 2018), on October 6–10, 2018, in San Antonio, TX.
- Fujifilm Showcases Expanded ELUXEO® Platform and Advanced Surgical Visualization System at ACG 2018
- 10/4/2018 10:00:00 AM
- (Booth #501) – FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy and FUJIFILM New Development, U.S.A., Inc. will exhibit their advanced surgical and endoscopic visualization systems at ACG 2018, the American College of Gastroenterology’s Annual Meeting from October 5-10, 2018, at the Pennsylvania Convention Center in Philadelphia, PA.
